Companies / Switzerland
Breakthrough Cancer Vaccine Receives Approval
July 2007 | Industry NewsUS biotech firm Northwest Biotherapeutics has had its experimental brain cancer vaccine DCVax-Brain approved in Switzerland, making it the first country to register the new drug.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
